Innoviva, Inc. ( INVA) - Key Metrics
INVA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.58 | $2.19 | $0.73 | $0.71 |
| 2025Q3 | $1.56 | $1.30 | $0.72 | $0.70 |
| 2025Q2 | $1.60 | $1.01 | $0.70 | $0.70 |
| 2025Q1 | $1.41 | -$0.74 | $0.78 | $0.78 |
INVA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 2.28 |
| 2025Q3 | ? | 3.50 |
| 2025Q2 | ? | 4.96 |
| 2025Q1 | ? | -6.10 |
INVA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.01% | ? |
| 2025Q4 | 3.57% | ? |
| 2025Q3 | 3.86% | ? |
| 2025Q2 | 3.49% | ? |
| 2025Q1 | 4.28% | ? |
INVA
Price: $22.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 6.26 USD
P/E Ratio: 3.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 549332
Ebitda: 66.9 millionMarket Capitalization: 1.6 billion